This opportunity is no longer accepting applications.
grant RFA-HL-23-010

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

This grant opportunity seeks applications to further develop technologies or platforms that enhance predictive, diagnostic, and therapeutic solutions for heart, lung, blood, and sleep disorders. It targets projects that have already overcome major feasibility challenges, with supportive preliminary data, but need more development and validation. Suitable projects should accelerate or transform…

This Funding Opportunity Announcement (FOA) solicits grant applications to further develop enabling technologies and transformative platforms to catalyze next-generation predictive, diagnostic and therapeutic products to address heart, lung, blood, and sleep (HLBS)-related disorders and diseases…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute

Awards & funding

Award Ceiling: $300,000
Award Amount: $300,000

Dates

Opportunity Released: January 24, 2022
Open for Submission: January 24, 2022
Submission Deadline: December 20, 2024
Application Window Closes: December 20, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.